Risk assessment of medicinal products on human reproduction and lactation: from data to labelling

Current effective version

PDF iconAdopted guideline

Reference numberEMEA/CHMP/203927/05
Effective from01/01/2009
KeywordsPregnancy, lactation, contraindication, non-clinical assessment, clinical assessment, risk assessment, labelling, summary of product characteristics (SmPC)
DescriptionThis document describes how to assess the risk of an adverse reproductive/developmental effect in human based on reproductive toxicity studies in animals and human clinical data. It addresses information to be included in the summary of product characteristics on how to use the medicinal product taking into account the nature of the risk.

Document history

First version

Current version

PDF iconAdopted guideline

PDF iconDraft guideline

In operation: 01/01/2009–present

Published: 23/03/2006

Related content

How useful was this page?

Add your rating